AAN52478.1
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Related Accession #
NCBI Official Full Name
NOD2
NCBI Official Synonym Full Names
nucleotide-binding oligomerization domain containing 2
NCBI Official Synonym Symbols
CD; ACUG; BLAU; IBD1; Nlrc2; Card15; F830032C23Rik [Similar Products]
NCBI Protein Information
nucleotide-binding oligomerization domain-containing protein 2; caspase recruitment domain family, member 15; caspase recruitment domain-containing protein 15
UniProt Protein Name
Nucleotide-binding oligomerization domain-containing protein 2
UniProt Synonym Protein Names
Caspase recruitment domain-containing protein 15
UniProt Synonym Gene Names
UniProt Entry Name
NOD2_MOUSE
UniProt Comments for Nod2
NOD2: Induces NF-kappa-B via RICK (CARDIAK, RIP2) and IKK- gamma. Confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Defects in NOD2 are the cause of Blau syndrome (BS). BS is a rare autosomal dominant disorder characterized by early-onset granulomatous arthritis, uveitis and skin rash. Defects in NOD2 are a cause of susceptibility to inflammatory bowel disease type 1 (IBD1). IBD1 is a chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology. It is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but most frequently it involves the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints. Defects in NOD2 are the cause of sarcoidosis early-onset (EOS). EOS is a form of sarcoidosis manifesting in children younger than 4 years of age. Sarcoidosis is an idiopathic, systemic, inflammatory disease characterized by the formation of immune granulomas in involved organs. Granulomas predominantly invade the lungs and the lymphatic system, but also skin, liver, spleen, eyes and other organs may be involved. Early- onset sarcoidosis is quite rare and has a distinct triad of skin, joint and eye disorders, without apparent pulmonary involvement. Compared with an asymptomatic and sometimes naturally disappearing course of the disease in older children, early-onset sarcoidosis is progressive and in many cases causes severe complications, such as blindness, joint destruction and visceral involvement. 2 isoforms of the human protein are produced by alternative initiation.
Cellular Component: signalosome; cytoskeleton; protein complex; cell surface; cytoplasm; plasma membrane; intracellular; cytosol; vesicle
Molecular Function: endodeoxyribonuclease activity, producing 5'-phosphomonoesters; protein binding; peptidoglycan binding; enzyme binding; CARD domain binding; nucleotide binding; protein kinase binding; ATP binding; muramyl dipeptide binding
Biological Process: positive regulation of dendritic cell antigen processing and presentation; maintenance of gastrointestinal epithelium; response to lipopolysaccharide; positive regulation of interleukin-1 beta secretion; positive regulation of interleukin-10 production; negative regulation of interleukin-2 production; activation of NF-kappaB transcription factor; regulation of apoptosis; positive regulation of phagocytosis; detection of muramyl dipeptide; cytokine production during immune response; detection of biotic stimulus; positive regulation of oxidoreductase activity; positive regulation of interleukin-17 production; negative regulation of interleukin-12 production; positive regulation of T-helper 2 type immune response; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of dendritic cell cytokine production; positive regulation of interleukin-6 production; positive regulation of tumor necrosis factor production; protein oligomerization; negative regulation of interleukin-18 production; positive regulation of peptidyl-tyrosine phosphorylation; defense response to Gram-positive bacterium; innate immune response in mucosa; response to muramyl dipeptide; inhibition of NF-kappaB transcription factor; positive regulation of B cell activation; defense response to bacterium; positive regulation of transcription from RNA polymerase II promoter; negative regulation of T cell mediated immunity; positive regulation of epithelial cell proliferation; positive regulation of nitric-oxide synthase biosynthetic process; activation of immune response; detection of bacterium; positive regulation of interleukin-12 production; positive regulation of JNK cascade; defense response; signal transduction; positive regulation of stress-activated MAPK cascade; response to exogenous dsRNA; positive regulation of MAPKKK cascade; negative regulation of interferon-gamma production; response to peptidoglycan; positive regulation of cell proliferation; positive regulation of innate immune response; negative regulation of inflammatory response to antigenic stimulus; inflammatory response; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; positive regulation of Notch signaling pathway; positive regulation of humoral immune response mediated by circulating immunoglobulin; immune system process; positive regulation of antibacterial peptide biosynthetic process; negative regulation of toll-like receptor 2 signaling pathway; positive regulation of phosphoinositide 3-kinase activity; negative regulation of tumor necrosis factor production; immunoglobulin production during immune response; positive regulation of interleukin-1 beta production; positive regulation of protein ubiquitination; regulation of inflammatory response; innate immune response
Research Articles on Nod2
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Pathways associated with anti-Nod2 antibody
Organs/Tissues associated with anti-Nod2 antibody
|